e-SQUARE

healthcare online

                                 Vol. 1, No. 24, March 2, 2003

 
Editorial
Protein & Stroke
Wound Excision & Burn
Colon Cancer
Hepatitis C Therapy
Genetic Marker
Arthritis and Heart Risk
New Products

 

Editorial Team

Omar Akramur Rab, MBBS, FCGP, FIAGP, FRSH (UK) 
Latifa Nishat, MBBS
  Shaokat Zaman, MBBS
Abdur Rahman, BBA
Thwe Thwe Prue, 

Web Developer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Editorial

 e- SQUARE- Aiming High       

 

Dear Doctor:

We're sure you are enjoying reading this e-newsletter full of valuable health and wellness information. This issue of "e-SQUARE" features a variety of contents including Protein & stroke, Wound excision & burn, Colon cancer, Hepatitis C therapy, Genetic marker, Arthritis and heart risk.

If you have problems with this service or any thoughts about our healthcare online, please mail us. We are just one click away! 

WE ALWAYS VALUE YOUR FEEDBACK.

Wish you all a very happy, healthy and prosperous life.

Yours sincerely,

Editorial Team

 Reply Mode : e-square@squaregroup.com 

The views expressed in this publication do not necessarily reflect those of its editor or SQUARE PHARMACEUTICALS LTD.

 

 

Protein & Stroke

A possible risk factor for stroke                                                                      Back to Features

A natural part of protein produced by the body may be to blame for a person's increased risk of stroke. A study found the risk of stroke was more than four-times higher in people with the highest homocysteine levels compared to those with the lowest levels. Homocysteine is an amino acid produced in the body. High levels can make blood clot more easily. The study involved 80 patients with coronary heart disease who had ischemic strokes, during more than eight years of follow-up and 80 patients who remained free of stroke or any recurrent events throughout the study. Researchers found the stroke patients had higher homocysteine levels. In addition, two-thirds of stroke patients had higher homocysteine levels than their matched controls. How homocysteine increases these risks is unclear. Some evidence indicates it may damage blood vessels and predispose people to forming fatty deposits and blood clots in arteries.

SOURCE: Ivanhoe Newswire

 

Wound Excision & Burn

Best treatment for burns                                                      Back to Features

A new study shows, not only is early burn wound excision safe, but also superior to other conservative treatments. Researchers studied 35 severely burned children responded to two different treatments. Twenty of the children were treated with early burn wound excision within 24 hours after the injury. The other 15 children were treated more conservatively. They were treated with a topical treatment for five days before their burn wounds were surgically removed. The patients who were treated with early burn wound excision had minimal adverse effects. This treatment did not increase caloric demands and controlled the inflammatory response. Overall, researchers said immediate surgical intervention was superior to the conservative topical treatment and delayed excision. Researchers concluded that immediate burn wound excision should be considered as the treatment of choice for full-thickness burns.

SOURCE: Archives of Surgery, 2003; 138:127-132

 

Colon Cancer

Calcium slows colon cancer                                                 Back to Features

Doctors recently reported the same bacterial toxin that causes traveler's diarrhea could slow down the growth of colon cancer cells. Calcium seems to be a very important part of the process. Researchers say the toxin that causes traveler's diarrhea appears to create an opening that allows calcium into the cells. Researchers write, dietary calcium is the mediator of this antiproliferative effect. They explain  that the toxin activates a receptor, GCC, which in turn causes a channel to open and calcium to enter. The toxin and calcium interact with one another to slow the growth of the cancer cell. When the toxin connects with the GCC receptor, two events are set off. First, intestinal diarrhea and then cell growth is slowed.

SOURCE: Proceedings of the National Academy of Sciences, 2003; published in Feb. 10,

 

Hepatitis C Therapy

Improved Hepatitis C survival rate                                      Back to Features 

Researchers found a current hepatitis C therapy may also help people with liver cancer caused by hepatitis C to live longer. Researchers say when given after surgery to remove the cancer the drug seems to reduce the occurrence of new cancer locations. The study involve 74 patients with cirrhosis, a potentially life-threatening condition that occurs when scarring damages the liver. After all patients had their lesions removed through therapy, 49 patients were assigned to receive interferon three times a week for 48 weeks. Twenty-five did not receive treatment. Results of the study show of the 49 patients treated with interferon, 21 patients showed a sustained biochemical response and 14 patients showed a sustained virologic response to the treatment. The rate of recurrence of new cancer in distant body parts was similar in the patients treated with interferon and untreated patients. However, the rates of second or third recurrences seemed to be lower in the interferon group than in the untreated group. Patients treated with interferon had a survival rate of 68 percent after five years and 53 percent after seven years. Untreated patients had a survival rate of 48 percent after five years and 23 percent after seven years.

SOURCE: Annals of Internal Medicine, 2003;138:299-306

 

Genetic Marker

Genetic marker for longevity identified!                              Back to Features

Scientists for the first time have identified a common genetic mutation in the people over 100 years old, a finding they say could be a key to discovering a way to avoid the ravages of aging. In a study researcher found that centenarians were five times more likely than others to have the same mutation in their mitochondrial DNA. In the study of a group of 52 centenarians, the researchers found a common mutation in the same main control region. Looking at mitochondrial DNA in white blood cells, they  found that 17% of the 52 had a specific mutation called C150 T transition, compared with only 3.4% of 117 people under the age of 99.

Source: Reuters Health

 

Arthritis and Heart Risk

 Arthritis increases heart risk                                               Back to Feature

Women with rheumatoid arthritis (RA) are more likely to have a heart attack than their peers without arthritis. Researchers behind a new study say RA should be considered a risk factor for heart attack and drug therapy should be considered to reduce the risk. This study examined the link between RA, heart attack and stroke. In the study 114,342 women were included. There were 527 cases of RA and 3,622 cases of heart attack and stroke. Researchers conclude, participants with rheumatoid arthritis had a significantly increased risk of myocardial infarction, but not stroke, compared with those without rheumatoid arthritis. Doctors say atherosclerosis has been known to have an inflammatory component and it may be similar to the inflammation associated with RA.

SOURCE: Ivanhoe Newswire

 

SQUARE Products introduced in 2003         Back to Features

            Product                                    Almex
           
Generic Name                      
   Albendazole
           
Strength                                 
200mg/5 ml
           
Dosage form                          
Suspension
           
Therapeutic Category          
Anti-helminthics          

            Product                                     Efo
           
Generic Name                         
Formoterol Fumerate
           
Strength                                   
12 mcg/ cozycapg
           
Dosage form                           
Dry powder inhaler
           
Therapeutic Category           
Anti-asthma    

            Product                                     Zycort
           
Generic Name                    
     Budesonide 
           
Strength                                   
200 mcg/cozy cap
           
Dosage form                           
Dry powder inhaler 
           
Therapeutic Category           
Anti-asthma

Back to Features                                                                                                   Continued...  

                               

 

We have sent this e-mail message to you in the belief that this service will be of interest. If you want to be removed from our mailing lists please send an e-mail to e-square@squaregroup.com quoting "unsubscribe" in the subject line.